Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06270875 · ClinicalTrials.gov registry record · NA

Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)

A NA study of Chronic Illness and NYHA Class II-IV Heart Failure, sponsored by University of Alabama at Birmingham.

Active
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06270875: Active NA study of Chronic Illness and NYHA Class II-IV Heart Failure, sponsored by University of Alabama at Birmingham.

NCT06270875 is a NA study of Chronic Illness and NYHA Class II-IV Heart Failure that is active but no longer recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 10 participants, below the 593-participant average among 5 other Chronic Illness trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06270875, a NA study of Chronic Illness and NYHA Class II-IV Heart Failure, is active but no longer recruiting, sponsored by University of Alabama at Birmingham.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Using the MOST framework, factorial pilot design, and an iterative, community-based process, the purpose of this study is to pilot test to further develop and refine a palliative care (PC) intervention addressing pain of Black adults (age \> 18) with advanced HF. Thirty-six persons with advancing heart failure (HF) will be randomized to receive one of 16 conditions (different combinations of navigator coach-delivered PC pain intervention components).

Primary Outcome

Proportion of participants who complete assigned intervention components and study-related assessments.

Interventions

  • BEHAVIORAL ADAPT HF

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2024-10-02
Est. Completion 2027-06-30
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the registry record for NCT06270875 still lists

NCT06270875 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 593-participant average among 5 other Chronic Illness trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Chronic Illness appearing as the primary indexed condition, and to 1 intervention - of which ADAPT HF is the first listed.

NCT06270875 reports a single indexed study location in Alabama.

Frequently Asked Questions

What is clinical trial NCT06270875 about?

NCT06270875 is a clinical study titled "Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)". Using the MOST framework, factorial pilot design, and an iterative, community-based process, the purpose of this study is to pilot test to further develop and refine a palliative care (PC) intervention addressing pain of Black adults (age \> 18) with advanced HF. Thirty-six persons with advancing he...

What is the current status of trial NCT06270875?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-10-02. Estimated completion is 2027-06-30.

What conditions does trial NCT06270875 study?

This clinical trial studies the following conditions: Chronic Illness, NYHA Class II-IV Heart Failure.

What interventions are being tested in trial NCT06270875?

The interventions under investigation include: ADAPT HF (BEHAVIORAL).

Who is sponsoring clinical trial NCT06270875?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06270875 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06270875, the US trial registry maintained by the National Library of Medicine. NCT06270875 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.